WALTHAM, Mass. and SARASOTA, Fla., Dec.
19, 2018 /PRNewswire/ -- Thermo Fisher Scientific Inc.
(NYSE: TMO), the world leader in serving science, and Roper
Technologies, Inc. (NYSE: ROP), a leading diversified technology
company, today announced that Thermo
Fisher's pending acquisition of Gatan, Inc., a wholly owned
subsidiary of Roper, requires further review by the Competition and
Markets Authority (CMA) in the UK. Both parties continue to work
cooperatively with the CMA through the review process. All other
regulatory approval conditions have been satisfied.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in
serving science, with revenues of more than $20 billion and approximately 70,000 employees
globally. Our mission is to enable our customers to make the world
healthier, cleaner and safer. We help our customers accelerate life
sciences research, solve complex analytical challenges, improve
patient diagnostics, deliver medicines to market and increase
laboratory productivity. Through our premier brands - Thermo
Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and
Unity Lab Services - we offer an unmatched combination of
innovative technologies, purchasing convenience and comprehensive
support. For more information, please visit
www.thermofisher.com.
About Roper Technologies
Roper Technologies is a constituent of the S&P 500, Fortune
1000 and the Russell 1000 indices. Roper operates businesses that
design and develop software (both license and
software-as-a-service) and engineered products and solutions for a
variety of niche end markets. Additional information about Roper is
available on the company's website at www.ropertech.com.
Media Contact Information:
Karen Kirkwood
Phone: 781-622-1306
E-mail: karen.kirkwood@thermofisher.com
Website: www.thermofisher.com
Investor Contact Information:
Ken Apicerno
Phone: 781-622-1294
E-mail: ken.apicerno@thermofisher.com
Roper Technologies Investor Relations
Phone: 941-556-2601
E-mail: investor-relations@ropertech.com
Website: www.ropertech.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/gatan-acquisition-requires-further-uk-review-300768811.html
SOURCE Thermo Fisher Scientific